988 related articles for article (PubMed ID: 14974914)
1. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
3. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
4. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
[TBL] [Abstract][Full Text] [Related]
5. Novel germline mutations in the SDHB and SDHD genes in Japanese pheochromocytomas.
Isobe K; Minowada S; Tatsuno I; Suzukawa K; Nissato S; Nanmoku T; Hara H; Yashiro T; Kawakami Y; Takekoshi K
Horm Res; 2007; 68(2):68-71. PubMed ID: 17308434
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
9. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology.
Douwes Dekker PB; Hogendoorn PC; Kuipers-Dijkshoorn N; Prins FA; van Duinen SG; Taschner PE; van der Mey AG; Cornelisse CJ
J Pathol; 2003 Nov; 201(3):480-6. PubMed ID: 14595761
[TBL] [Abstract][Full Text] [Related]
10. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
[TBL] [Abstract][Full Text] [Related]
11. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
[TBL] [Abstract][Full Text] [Related]
12. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?
Cascón A; Montero-Conde C; Ruiz-Llorente S; Mercadillo F; Letón R; Rodríguez-Antona C; Martínez-Delgado B; Delgado M; Díez A; Rovira A; Díaz JA; Robledo M
Genes Chromosomes Cancer; 2006 Mar; 45(3):213-9. PubMed ID: 16258955
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
[TBL] [Abstract][Full Text] [Related]
14. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
[TBL] [Abstract][Full Text] [Related]
15. The genetics of paragangliomas: a review.
Martin TP; Irving RM; Maher ER
Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
[TBL] [Abstract][Full Text] [Related]
16. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez-Roqueplo AP; Favier J; Rustin P; Rieubland C; Crespin M; Nau V; Khau Van Kien P; Corvol P; Plouin PF; Jeunemaitre X;
Cancer Res; 2003 Sep; 63(17):5615-21. PubMed ID: 14500403
[TBL] [Abstract][Full Text] [Related]
19. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
[TBL] [Abstract][Full Text] [Related]
20. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
Hensen EF; Siemers MD; Jansen JC; Corssmit EP; Romijn JA; Tops CM; van der Mey AG; Devilee P; Cornelisse CJ; Bayley JP; Vriends AH
Clin Endocrinol (Oxf); 2011 Nov; 75(5):650-5. PubMed ID: 21561462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
